Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Raetz

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessmentSarah Alexander, Jason D Pole, Paul Gibson, et al.
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|February 6, 2014
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trialMichael A Pulsipher, Bryan Langholz, Donna A Wall, et al.
JAMA Network Open|August 28, 2020
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical TrialSmita Bhatia, Lindsey Hageman, Yanjun Chen, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
The Lancet. Oncology|June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
Pediatric Blood & Cancer|August 17, 2023
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemiaRozalyn L Rodwin, Natalie J DelRocco, Emily Hibbitts, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessmentSarah Alexander, Jason D Pole, Paul Gibson, et al.
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|February 6, 2014
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trialMichael A Pulsipher, Bryan Langholz, Donna A Wall, et al.
JAMA Network Open|August 28, 2020
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical TrialSmita Bhatia, Lindsey Hageman, Yanjun Chen, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
The Lancet. Oncology|June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
Pediatric Blood & Cancer|August 17, 2023
Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemiaRozalyn L Rodwin, Natalie J DelRocco, Emily Hibbitts, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Pageof 7